Annual results moved in different directions for sales and profit. Revenue rose from KRW 85.3 billion in 2022 to KRW 148.7 billion in 2023 (up 74.2% year on year), KRW 204.9 billion in 2024 (up 37.8%), and KRW 224.1 billion in 2025 (up 9.4%).
Sales rose for three consecutive years from 2023 through 2025, and 2025 was the largest year and 2022 the smallest among 2022 to 2025. Press reports described 2025 revenue as a record high.
Operating profit rose from KRW 9.51 billion in 2022 to KRW 24 billion in 2023 (up 152.4%) and KRW 33.6 billion in 2024 (up 40.2%), making 2024 the largest year. It then fell 19.3% to KRW 27.1 billion in 2025. Operating margin moved from 11.1% in 2022 and 16.1% in 2023 to 16.4% in 2024 before declining to 12.1% in 2025.
Net profit attributable to controlling shareholders peaked at KRW 28.3 billion in 2024 and fell 22.9% to KRW 21.8 billion in 2025.
Press reports said selling and administrative expenses rose to KRW 61.1 billion in 2025, which the company attributed to offline store launches, new skincare brand launches, and marketing and logistics costs for U.S. expansion. Operating cash flow swung from -KRW 9.31 billion in 2024 to KRW 43 billion in 2025.
On a quarterly basis, operating profit was KRW 6.18 billion in Q3 2025 and KRW 6.62 billion in Q4 2025, fell to KRW 3.69 billion in Q1 2026, rebounded to KRW 6.81 billion in Q2 2026, and dropped to KRW 1.88 billion in Q3 2026.
According to press calculations, the Q3 2026 operating margin was 3.4%, down from 11.6% a year earlier. The company cited front-loaded overseas investment, one-time distribution restructuring costs, and the disposal of excess 2024 second-half stock with inventory provisions as reasons for the Q3 decline.
Net profit attributable to controlling shareholders over the most recent four quarters totaled KRW 14.4 billion.